The award supports an innovative project that represents an exciting change in research direction for an early stage investigator. The highly regarded R01 grant, which will provide $1.25 million in funding over five years, will support Murin’s research studying how antibodies enable Natural Killer (NK) cells of our innate immune system to target HIV, for which the precise mechanisms remain unclear.